Erratum: Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer [Ann Oncol, 27,(2016) (2032-2038)] DOI: 10.1093/annonc/mdw317

F. Janku, L. K. Johnson, D. D. Karp, J. T. Atkins, P. A. Singleton, J. Moss

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations

Abstract

In the original article, Figure 2 and Figure 3 legends referred to red curves instead of green curves. The legends have now been corrected.

Original languageEnglish (US)
Pages (from-to)1076
Number of pages1
JournalAnnals of Oncology
Volume29
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Erratum: Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer [Ann Oncol, 27,(2016) (2032-2038)] DOI: 10.1093/annonc/mdw317'. Together they form a unique fingerprint.

Cite this